AMN

SEC source: 0001209191-21-002678 · doc4.xml · nonDerivative · entry 1

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,245

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units (RSUs).

SEC source: 0001209191-21-001706 · doc4.xml · derivative · entry 10

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,009 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_price: The RSUs identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F10 · derivative.exercise_date: The RSUs identified in this row were granted on January 5, 2018 and vest in three tranches on each of the first, second and third anniversaries of the grant date.

F8 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-21-001706 · doc4.xml · nonDerivative · entry 7

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,024

F4 · kind: The sale of 788 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F5 · price: The price reported in this row represents a weighted average price of $69.8515 per share. These shares were sold in multiple transactions at prices ranging from $69.83 to $69.875, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-21-001706 · doc4.xml · nonDerivative · entry 6

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,812

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-21-001706 · doc4.xml · nonDerivative · entry 5

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,998

F3 · kind: The acquisition of Common Stock set forth in this row resulted from the vesting of a Performance Restricted Stock Unit ("PRSU") award granted by the Company on January 5, 2018. The ultimate number of PRSUs that could have been earned and vested under this award depended on (1) the total shareholder return for the Company relative to the companies in the Russell 2000 Index as of December 31, 2017 for the 3-year period beginning on January 1, 2018 and ended December 31, 2020 ("Relative TSR") and (2) whether the Company's absolute total shareholder return for the same period was positive or negative (collectively, the "TSR Measurement"). The Compensation Committee performed the TSR Measurement for this award on January 4, 2021. The Company's Relative TSR measured in the 78th percentile and its absolute total shareholder return for the period was positive. Based on these results, the maximum amount of PRSUs for this award were deemed earned and vested.

SEC source: 0001209191-21-001706 · doc4.xml · nonDerivative · entry 4

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,556

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-21-001706 · doc4.xml · nonDerivative · entry 3

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,949

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units (RSUs).

SEC source: 0001209191-21-001704 · doc4.xml · derivative · entry 9

Scott Brian M. · CIK 0001510242 · CFO/CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,348 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: The RSUs identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F8 · derivative.exercise_date: The RSUs identified in this row were granted on January 5, 2018 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service.

F6 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-21-001704 · doc4.xml · nonDerivative · entry 6

Scott Brian M. · CIK 0001510242 · CFO/CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,006

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-21-001704 · doc4.xml · nonDerivative · entry 5

Scott Brian M. · CIK 0001510242 · CFO/CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,775

F3 · kind: The acquisition of Common Stock set forth in this row resulted from the vesting of a Performance Restricted Stock Unit ("PRSU") award granted by the Company on January 5, 2018. The ultimate number of PRSUs that could have been earned and vested under this award depended on (1) the total shareholder return for the Company relative to the companies in the Russell 2000 Index as of December 31, 2017 for the 3-year period beginning on January 1, 2018 and ended December 31, 2020 ("Relative TSR") and (2) whether the Company's absolute total shareholder return for the same period was positive or negative (collectively, the "TSR Measurement"). The Compensation Committee performed the TSR Measurement for this award on January 4, 2021. The Company's Relative TSR measured in the 78th percentile and its absolute total shareholder return for the period was positive. Based on these results, the maximum amount of PRSUs for this award were deemed earned and vested.

SEC source: 0001209191-21-001704 · doc4.xml · nonDerivative · entry 4

Scott Brian M. · CIK 0001510242 · CFO/CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,769

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-21-001704 · doc4.xml · nonDerivative · entry 3

Scott Brian M. · CIK 0001510242 · CFO/CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,574

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units (RSUs).

SEC source: 0001209191-21-002471 · doc4.xml · nonDerivative · entry 2

SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,605

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-21-002471 · doc4.xml · nonDerivative · entry 1

SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,470

F1 · kind: The acquisition of Common Stock set forth in this row resulted from the vesting of a Performance Restricted Stock Unit ("PRSU") award granted by the Company on January 5, 2018. The ultimate number of PRSUs that could have been earned and vested under this award depended on (1) the total shareholder return for the Company relative to the companies in the Russell 2000 Index as of December 31, 2017 for the 3-year period beginning on January 1, 2018 and ended December 31, 2020 ("Relative TSR") and (2) whether the Company's absolute total shareholder return for the same period was positive or negative (collectively, the "TSR Measurement"). The Compensation Committee performed the TSR Measurement for this award on January 4, 2021. The Company's Relative TSR measured in the 78th percentile and its absolute total shareholder return for the period was positive. Based on these results, the maximum amount of PRSUs for this award were deemed earned and vested.

SEC source: 0001209191-21-001706 · doc4.xml · derivative · entry 9

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,642

Underlying: Common Stock · 4,642 shares

Expires not disclosed

F6 · derivative.exercise_price: The RSUs identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F9 · derivative.exercise_date: The RSUs identified in this row were granted on January 4, 2021 and vest in three tranches on each of the first, second and third anniversaries of the grant date.

F8 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-21-001704 · doc4.xml · derivative · entry 8

Scott Brian M. · CIK 0001510242 · CFO/CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,890

Underlying: Common Stock · 9,890 shares

Expires not disclosed

F4 · derivative.exercise_price: The RSUs identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F7 · derivative.exercise_date: The RSUs identified in this row were granted on January 4, 2021 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service.

F6 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-21-002180 · doc4.xml · derivative · entry 3

Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,923

Underlying: Common Stock · 6,923 shares

Expires not disclosed

F3 · derivative.exercise_price: The RSUs identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F4 · derivative.exercise_date: The RSUs identified in this row were granted on January 4, 2021 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service.

F5 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-21-001710 · doc4.xml · derivative · entry 3

Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,326

Underlying: Common Stock · 1,286 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: The RSUs identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F4 · derivative.exercise_date: The RSUs identified in this row were granted on January 3, 2019 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service.

F5 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-21-001710 · doc4.xml · nonDerivative · entry 2

Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,665

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-21-001710 · doc4.xml · nonDerivative · entry 1

Hagan Mark Christopher · CIK 0001806483 · Chief Information and Digital

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,194

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units (RSUs).

SEC source: 0001209191-21-001706 · doc4.xml · derivative · entry 8

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,379

Underlying: Common Stock · 1,339 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_price: The RSUs identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F7 · derivative.exercise_date: The RSUs identified in this row were granted on January 3, 2019 and vest in three tranches on each of the first, second and third anniversaries of the grant date.

F8 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-21-001706 · doc4.xml · nonDerivative · entry 2

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,940

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-21-001706 · doc4.xml · nonDerivative · entry 1

Jackson Denise L · CIK 0001320242 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,491

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units (RSUs).

SEC source: 0001209191-21-001704 · doc4.xml · derivative · entry 7

Scott Brian M. · CIK 0001510242 · CFO/CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,160

Underlying: Common Stock · 2,096 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: The RSUs identified in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F5 · derivative.exercise_date: The RSUs identified in this row were granted on January 3, 2019 and vest in three tranches on each of the first, second and third anniversaries of the grant date and the grantee's provision of three periods of credited service.

F6 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-21-001704 · doc4.xml · nonDerivative · entry 2

Scott Brian M. · CIK 0001510242 · CFO/CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,226

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-21-001704 · doc4.xml · nonDerivative · entry 1

Scott Brian M. · CIK 0001510242 · CFO/CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,805

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units (RSUs).

SEC source: 0001209191-20-064891 · doc4.xml · nonDerivative · entry 3

SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,296

F3 · kind: The sale of 8,301 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F4 · price: The price reported in this row represents a weighted average price of $68.040864 per share. These shares were sold in multiple transactions at prices ranging from $67.10 to $68.79, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

F5 · balance_after: The number of shares reflected in this column does not include 101,243 vested RSUs that the Reporting Person elected to defer at the time of grant until her separation from service with the Company.

SEC source: 0001209191-20-064891 · doc4.xml · derivative · entry 4

SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 13,687 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_price: The RSUs were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each RSU represents a contingent right to receive one share of AMN Common Stock.

F7 · derivative.exercise_date: The RSUs were granted on December 19, 2017 and vest on the first, second and third anniversary of the grant date and the grantees provision of three periods of credited service.

F8 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-20-064891 · doc4.xml · nonDerivative · entry 2

SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,597

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-20-064891 · doc4.xml · nonDerivative · entry 1

SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,983

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units (RSUs).

SEC source: 0001209191-20-064554 · doc4.xml · nonDerivative · entry 5

SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,296

F4 · kind: The sale of 8,593 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F5 · price: The price reported in this row represents a weighted average price of $68.326843 per share. These shares were sold in multiple transactions at prices ranging from $67.38 to $68.74, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-21-005544 · doc4a.xml · nonDerivative · entry 5

SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,296

F4 · kind: The sale of 8,593 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F5 · price: The price reported in this row represents a weighted average price of $68.326843 per share. These shares were sold in multiple transactions at prices ranging from $67.38 to $68.74, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-20-064554 · doc4.xml · derivative · entry 9

SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,543

Underlying: Common Stock · 7,322 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_price: The RSUs reflected in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

F12 · derivative.exercise_date: The RSUs reflected in this row were granted on December 17, 2018 and vest on the first, second and third anniversary of the grant date and the grantees provision of three periods of credited service.

F10 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-20-064554 · doc4.xml · nonDerivative · entry 4

SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,889

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-20-064554 · doc4.xml · nonDerivative · entry 3

SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,771

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · kind: Common Stock acquired on the vesting of RSUs.

SEC source: 0001209191-21-005544 · doc4a.xml · derivative · entry 9

SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,543

Underlying: Common Stock · 7,322 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F9 · derivative.exercise_price: The RSUs reflected in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

F13 · derivative.exercise_date: The RSUs reflected in this row were granted on December 17, 2018 and vest on the first, second and third anniversary of the grant date and the grantees provision of three periods of credited service.

F11 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-21-005544 · doc4a.xml · nonDerivative · entry 4

SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,889

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-21-005544 · doc4a.xml · nonDerivative · entry 3

SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,771

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · kind: Common Stock acquired on the vesting of RSUs.

SEC source: 0001209191-20-064554 · doc4.xml · derivative · entry 8

SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,906

Underlying: Common Stock · 6,849 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_price: The RSUs reflected in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

F11 · derivative.exercise_date: The RSUs reflected in this row were granted on December 16, 2019 and vest on the first, second and third anniversary of the grant date and the grantees provision of three periods of credited service.

F10 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-20-064554 · doc4.xml · derivative · entry 7

SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,882

Underlying: Common Stock · 18,882 shares

Expires not disclosed

F8 · derivative.exercise_price: The RSUs reflected in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

F9 · derivative.exercise_date: The RSUs reflected in this row were granted on December 16, 2020 and vest on the first, second and third anniversary of the grant date and the grantees provision of three periods of credited service.

F10 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-20-064554 · doc4.xml · nonDerivative · entry 2

SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,449

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-20-064554 · doc4.xml · nonDerivative · entry 1

SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,145

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units (RSUs).

SEC source: 0001209191-21-005544 · doc4a.xml · derivative · entry 8

SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,906

Underlying: Common Stock · 6,849 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F9 · derivative.exercise_price: The RSUs reflected in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

F12 · derivative.exercise_date: The RSUs reflected in this row were granted on December 16, 2019 and vest on the first, second and third anniversary of the grant date and the grantees provision of three periods of credited service.

F11 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-21-005544 · doc4a.xml · derivative · entry 7

SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,625

Underlying: Common Stock · 19,625 shares

Expires not disclosed

F8 · security: Due to an administrative error, the Form 4 filed by the Reporting Person on December 18, 2020 understated the number of RSUs granted on December 16, 2020. This Form 4 is being amended and restated to reflect that 19,625 RSUs were granted on December 16, 2020, and not the 18,882 RSUs previously reported.

F9 · derivative.exercise_price: The RSUs reflected in this row were granted pursuant to the AMN Healthcare 2017 Equity Plan. Each Restricted Stock Unit represents a contingent right to receive one share of AMN Common Stock.

F10 · derivative.exercise_date: The RSUs reflected in this row were granted on December 16, 2020 and vest on the first, second and third anniversary of the grant date and the grantees provision of three periods of credited service.

F11 · derivative.expiration_date: RSUs do not have an expiration date.

SEC source: 0001209191-21-005544 · doc4a.xml · nonDerivative · entry 2

SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,449

F2 · kind: Number of shares withheld for tax purposes.

SEC source: 0001209191-21-005544 · doc4a.xml · nonDerivative · entry 1

SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,145

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Common Stock acquired on the vesting of Restricted Stock Units (RSUs).

SEC source: 0001209191-20-064554 · doc4.xml · nonDerivative · entry 6

SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,296

F6 · kind: The reporting person transferred 20,000 shares of AMN Common Stock as a gift to charity.

F7 · balance_after: The number of shares reflected in this column does not include 101,243 vested RSUs that the Reporting Person elected to defer at the time of grant until her separation from service with the Company.

SEC source: 0001209191-21-005544 · doc4a.xml · nonDerivative · entry 6

SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,296

F6 · kind: The reporting person transferred 20,000 shares of AMN Common Stock as a gift to charity.

F7 · balance_after: The number of shares reflected in this column does not include 101,243 vested RSUs that the Reporting Person elected to defer at the time of grant until her separation from service with the Company.

SEC source: 0001209191-20-063020 · doc4.xml · nonDerivative · entry 1

SALKA SUSAN R · CIK 0001158584 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,296

F1 · kind: The sale of 5,988 shares of AMN Common Stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · price: The price reported in this row represents a weighted average price of $68.667068 per share. These shares were sold in multiple transactions at prices ranging from $68.335 to $69.13, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

SEC source: 0001209191-20-064495 · doc4.xml · nonDerivative · entry 1

HARRIS R JEFFREY · CIK 0001183645 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,496

F1 · kind: The reporting person transferred 1,800 shares of AMN Common Stock as a gift to charity.